PharmiWeb.com - Global Pharma News & Resources

Biotech - Press Releases

Date Title Company
04-Sep-2025 Onco3R Therapeutics Announces Approval of First Clinical Trial Application for Novel SIK3 inhibitor O3R-5671 in Autoimmune Diseases Onco3R Therapeutics
04-Sep-2025 PulseSight Therapeutics Provides New Insights into the Role of Iron and Transferrin in AMD, Supporting its PST-611 Vectorized Therapy for Dry AMD/Geographic Atrophy at EURETINA 2025 PulseSight Therapeutics
04-Sep-2025 Kuros Biosciences announces changes in the Board of Directors Kuros Biosciences
04-Sep-2025 NuCana to Present Data on NUC-7738’s Synergy with PD-1 Inhibitors at the ESMO Congress 2025 NuCana
04-Sep-2025 Health Economics Study on Ondine’s Steriwave® Selected for Oral Presentation at ICPIC 2025 in Geneva Ondine
04-Sep-2025 ArcaScience Raises $7M to Transform Drug Development with AI-Powered Benefit-Risk Intelligence ArcaScience
04-Sep-2025 Fidia Farmaceutici enters the UK market with the acquisition of Altacor Ltd Fidia Farmaceutici
04-Sep-2025 Resolution Therapeutics announces first patient dosed in Phase I/II EMERALD study of RTX001 for the treatment of end-stage liver disease Resolution Therapeutics
04-Sep-2025 Allegro appoints life sciences veteran as Chief Operating Officer to advance osteoarthritis treatment Allegro
04-Sep-2025 Moberg Pharma to Expand Board of Directors and Withdraw Share Issue Authorization Moberg Pharma
04-Sep-2025 ArcaScience Raises $7M to Transform Drug Development with AI-Powered Benefit-Risk Intelligence ArcaScience
04-Sep-2025 MultiOmic Health and BIO4 Campus Sign MoU to Advance Precision Medicine and Support Bioeconomy Growth in Serbia MultiOmic Health Limited
04-Sep-2025 MtoZ Biolabs Empowers Research with High-Throughput Shotgun Proteomics Analysis MtoZ Biolabs
03-Sep-2025 SMART Researchers Develop First-of-Its-Kind RNA Tool to Advance Cancer and Infectious Disease Research and Treatment Singapore-MIT Alliance for Research and Technology
02-Sep-2025 Naobios, Nuvonis and European Vaccine Initiative collaborate on manufacturing influenza challenge agent Andrew Lloyd Associates
28-Aug-2025 A Strategic Step Forward: Alphial S.r.l. Joins SGD Pharma SGD Pharma
28-Aug-2025 ZurzuvaeTM (Zuranolone) Becomes First and Only MHRA-Licensed Treatment for Mothers with Post-Natal Depression Biogen
28-Aug-2025 BioWin Days 2025: Belgian health innovators set to meet on September 23 and 24 Andrew Lloyd Associates
27-Aug-2025 Ciliatech obtains CE mark for eye implant Intercil® Uveal Spacer, novel treatment for patients with glaucoma Andrew Lloyd Associates
26-Aug-2025 Adva Biotechnology and Autolomous Announce Collaboration to Co-Lead the Digital Pioneer Program for Scalable Autologous Cell Therapy Manufacturing Adva Biotechnology